Miri Kim

Glioblastoma as an age-related neurological disorder in adults

L. Hou, C. James, V. Prabhu, 2021, Neuro-oncology advances.

Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma

C. James, D. Matei, L. Platanias, 2022, Journal of medicinal chemistry.

Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma

C. Horbinski, M. Schipma, D. Wainwright, 2021, Clinical Cancer Research.

A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer

P. Bommi, T. Walunas, E. Sieg, 2022, Brain, behavior, & immunity - health.

Indoleamine 2,3-dioxygenase 1 (IDO): A mediator of immunoresistance in adults with brain cancer treated with immunomodulatory therapy

D. Wainwright, L. Bollu, Erik Ladomersky, 2022, Immunotherapeutic Strategies for the Treatment of Glioma.

Automated mass screening for comorbidities of vitiligo using the National Health Insurance database.

J. Bae, C. Choi, Solam Lee, 2023, The Journal of investigative dermatology.